Felipe F. Casanueva

TL;DR: This Consensus Statement presents consensus recommendations highlighting how acromegaly management could be optimized in clinical practice, and discusses factors that would determine pharmacological choices as well as the proposed place of each agent in the guidelines.

TL;DR: Evidence-based approach consensus recommendations address important clinical issues regarding multidisciplinary management of acromegaly-related cardiovascular, endocrine, metabolic, and oncologic comorbidities, sleep apnea, and bone and joint disorders and their sequelae, as well as their effects on quality of life and mortality.

TL;DR: Examination of techniques, results, and side effects of surgery, radiotherapy, and medical therapy, and how advances in technology and novel techniques have changed the way these modalities have changed, emphasize how best to implement available treatment options as part of a multidisciplinary approach at Pituitary Tumor Centers of Excellence.

TL;DR: LAGH compounds may represent an advance over daily GH injections because of increased convenience and differing phamacodynamic properties, providing the potential for improved adherence and outcomes.

TL;DR: Anterior pituitary tumors arising from oral ectoderm-derived differentiated hormone-expressing lineages are classified according to cell type, size, location, secretory function and neoplastic behavior.